{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:16:09Z","timestamp":1793038569670,"version":"4.5.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2022]]},"DOI":"10.4103\/1673-5374.332145","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:51:21Z","timestamp":1639097481000},"page":"1745","source":"Crossref","is-referenced-by-count":22,"title":["Targeting the epigenome to treat neurodegenerative diseases or delay their onset: a perspective"],"prefix":"10.4103","volume":"17","author":[{"given":"Fabio","family":"Coppede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.332145-1","doi-asserted-by":"crossref","unstructured":"Copped\u00e8 F (2014) The potential of epigenetic therapies in neurodegenerative diseases. Front Genet 5:220.","DOI":"10.3389\/fgene.2014.00220"},{"key":"key-10.4103\/1673-5374.332145-2","doi-asserted-by":"crossref","unstructured":"Copped\u00e8 F (2020) Epigenetics of neuromuscular disorders. Epigenomics 12:2125-2139.","DOI":"10.2217\/epi-2020-0282"},{"key":"key-10.4103\/1673-5374.332145-3","doi-asserted-by":"crossref","unstructured":"Copped\u00e8 F (2021a) Epigenetic regulation in Alzheimer\u2019s disease: is it a potential therapeutic target? Expert Opin Ther Targets 25:283-298.","DOI":"10.1080\/14728222.2021.1916469"},{"key":"key-10.4103\/1673-5374.332145-4","doi-asserted-by":"crossref","unstructured":"Copped\u00e8 F (2021b) One-carbon epigenetics and redox biology of neurodegeneration. Free Radic Biol Med 170:19-33.","DOI":"10.1016\/j.freeradbiomed.2020.12.002"},{"key":"key-10.4103\/1673-5374.332145-5","doi-asserted-by":"crossref","unstructured":"Creighton SD, Stefanelli G, Reda A, Zovkic IB (2020) Epigenetic mechanisms of learning and memory: implications for aging. Int J Mol Sci 21:6918.","DOI":"10.3390\/ijms21186918"},{"key":"key-10.4103\/1673-5374.332145-6","doi-asserted-by":"crossref","unstructured":"Cummings J, Lee G, Zhong K, Fonseca J, Taghva K (2021) Alzheimer\u2019s disease drug development pipeline: 2021. Alzheimers Dement (N Y) 7:e12179.","DOI":"10.1002\/trc2.12179"},{"key":"key-10.4103\/1673-5374.332145-7","doi-asserted-by":"crossref","unstructured":"Fuso A, Nicolia V, Ricceri L, Cavallaro RA, Isopi E, Mangia F, Fiorenza MT, Scarpa S (2012) S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice. Neurobiol Aging 33:1482.","DOI":"10.1016\/j.neurobiolaging.2011.12.013"},{"key":"key-10.4103\/1673-5374.332145-8","doi-asserted-by":"crossref","unstructured":"Huaying C, Xing J, Luya J, Linhui N, Di S, Xianjun D (2021) A signature of five long non-coding RNAs for predicting the prognosis of Alzheimer\u2019s disease based on competing endogenous RNA networks. Front Aging Neurosci 12:598606.","DOI":"10.3389\/fnagi.2020.598606"},{"key":"key-10.4103\/1673-5374.332145-9","doi-asserted-by":"crossref","unstructured":"Lahiri DK, Maloney B, Zawia NH (2009) The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry 14:992-1003.","DOI":"10.1038\/mp.2009.82"},{"key":"key-10.4103\/1673-5374.332145-10","doi-asserted-by":"crossref","unstructured":"Lee ES, Chen H, Shepherd KR, Lamango NS, Soliman KF, Charlton CG (2004) The inhibitory role of methylation on the binding characteristics of dopamine receptors and transporter. Neurosci Res 48:335-344.","DOI":"10.1016\/j.neures.2003.11.010"},{"key":"key-10.4103\/1673-5374.332145-11","doi-asserted-by":"crossref","unstructured":"Monti N, Cavallaro RA, Stoccoro A, Nicolia V, Scarpa S, Kovacs GG, Fiorenza MT, Lucarelli M, Aronica E, Ferrer I, Copped\u00e8 F, Troen AM, Fuso A (2020) CpG and non-CpG Presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain. Epigenetics 15:781-799.","DOI":"10.1080\/15592294.2020.1722917"},{"key":"key-10.4103\/1673-5374.332145-12","doi-asserted-by":"crossref","unstructured":"Muralidharan A, Rahman J, Banerjee D, Hakim Mohammed AR, Malik BH (2020) Parkinsonism: a rare adverse effect of valproic acid. Cureus 12:e8782.","DOI":"10.7759\/cureus.8782"},{"key":"key-10.4103\/1673-5374.332145-13","doi-asserted-by":"crossref","unstructured":"Piepers S, Veldink JH, de Jong SW, van der Tweel I, van der Pol WL, Uijtendaal EV, Schelhaas HJ, Scheffer H, de Visser M, de Jong JM, Wokke JH, Groeneveld GJ, van den Berg LH (2009) Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis. Ann Neurol 66:227-234.","DOI":"10.1002\/ana.21620"},{"key":"key-10.4103\/1673-5374.332145-14","doi-asserted-by":"crossref","unstructured":"Rathore AS, Birla H, Singh SS, Zahra W, Dilnashin H, Singh R, Keshri PK, Singh SP (2021) Epigenetic modulation in Parkinson\u2019s disease and potential treatment therapies. Neurochem Res 46:1618-1626.","DOI":"10.1007\/s11064-021-03334-w"},{"key":"key-10.4103\/1673-5374.332145-15","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang X, Li R, Yang ZF, Wang YZ, Gong XL, Wang XM (2013) A DNA methyltransferase inhibitor, 5-aza-2\u2019-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson\u2019s disease-related genes in dopaminergic neurons. CNS Neurosci Ther 19:183-190.","DOI":"10.1111\/cns.12059"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:25:05Z","timestamp":1787163905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.332145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"alternative-id":["332145"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.332145","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}